Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC |
Nardi Steven M.VP of Manufacturing
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,187 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · derivative · entry 7 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,188 Underlying: Common Stock · 2,187 shares Expires 2023-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/13/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC |
Nardi Steven M.VP of Manufacturing
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 253 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · derivative · entry 6 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,188 Underlying: Common Stock · 253 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC |
Nardi Steven M.VP of Manufacturing
|
SaleCommon Stock | 2,700 | $8.30 | $22,410.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 4 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC |
Nardi Steven M.VP of Manufacturing
|
GrantCommon Stock | 2,440 | $1.48 | $3,611.20 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 18:28 UTC |
Nardi Steven M.VP of Manufacturing
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,934 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · derivative · entry 5 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,441 Underlying: Common Stock · 1,934 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 18:28 UTC |
Nardi Steven M.VP of Manufacturing
|
SaleCommon Stock | 1,934 | $8.35 | $16,139.23 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260 F1 · price: This transaction was executed in multiple trades at prices ranging from $8.30 to $8.375. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 18:28 UTC |
Nardi Steven M.VP of Manufacturing
|
GrantCommon Stock | 1,934 | $1.48 | $2,862.32 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,194 Read SEC document |
| April 27, 2017 Filed May 1, 2017 17:34 UTC |
McCreery John KChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-017664 · doc1.xml · derivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| March 28, 2017 Filed Mar 31, 2017 15:02 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014131 · doc1.xml · derivative · entry 2 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,288 Underlying: Common Stock · 2,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 28, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on March 28, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On March 28, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on March 28, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| March 28, 2017 Filed Mar 31, 2017 15:02 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionCommon Stock | 2,644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-014131 · doc1.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 22:56 UTC |
Susi Roger E.Director · CEO, President, Chairman · 10% owner
|
PurchaseCommon Stock | 5,000 | $8.65 | $43,250.00 |
DisclosureSEC source: 0001140361-17-005881 · doc1.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:56 UTC |
Susi Roger E.Director · CEO, President, Chairman · 10% owner
|
PurchaseCommon Stock | 5,000 | $8.55 | $42,750.00 |
DisclosureSEC source: 0001140361-17-005881 · doc1.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:58 UTC |
Casey Francis X.VP of Reg & Qual Assurance
|
Exercise / conversionRestricted Stock Units · Derivative | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001005 · doc1.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164 Underlying: Common Stock · 387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:58 UTC |
Casey Francis X.VP of Reg & Qual Assurance
|
Tax withholdingCommon Stock | 127 | $12.30 | $1,562.10 |
DisclosureSEC source: 0001140361-17-001005 · doc1.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,260 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:58 UTC |
Casey Francis X.VP of Reg & Qual Assurance
|
Exercise / conversionCommon Stock | 387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001005 · doc1.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:11 UTC |
Waldman Louis S.Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 1,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001014 · doc1.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,492 Underlying: Common Stock · 1,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:11 UTC |
Waldman Louis S.Controller
|
Tax withholdingCommon Stock | 380 | $12.30 | $4,674.00 |
DisclosureSEC source: 0001140361-17-001014 · doc1.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,871 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:11 UTC |
Waldman Louis S.Controller
|
Exercise / conversionCommon Stock | 1,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001014 · doc1.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:08 UTC |
Nardi Steven M.VP Manufacturing
|
Exercise / conversionRestricted Stock Units · Derivative | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001010 · doc1.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164 Underlying: Common Stock · 387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:08 UTC |
Nardi Steven M.VP Manufacturing
|
Tax withholdingCommon Stock | 127 | $12.30 | $1,562.10 |
DisclosureSEC source: 0001140361-17-001010 · doc1.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:08 UTC |
Nardi Steven M.VP Manufacturing
|
Exercise / conversionCommon Stock | 387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001010 · doc1.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:03 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,562 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-001007 · doc1.xml · derivative · entry 5 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,563 Underlying: Common Stock · 6,562 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 26,250 shares, was granted on 1/1/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. F3 · derivative.expiration_date: This option, representing a right to purchase a total of 26,250 shares, was granted on 1/1/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:03 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001007 · doc1.xml · derivative · entry 4 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,899 Underlying: Common Stock · 1,898 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:03 UTC |
ALLEN MONTY KDirector
|
GrantCommon Stock | 6,562 | $1.48 | $9,711.76 |
DisclosureSEC source: 0001140361-17-001007 · doc1.xml · nonDerivative · entry 3 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,340 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:03 UTC |
ALLEN MONTY KDirector
|
Tax withholdingCommon Stock | 620 | $12.30 | $7,626.00 |
DisclosureSEC source: 0001140361-17-001007 · doc1.xml · nonDerivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,778 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:03 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionCommon Stock | 1,898 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001007 · doc1.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:56 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Exercise / conversionRestricted Stock Units · Derivative | 617 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001002 · doc1.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,851 Underlying: Common Stock · 617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:56 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Tax withholdingCommon Stock | 202 | $12.30 | $2,484.60 |
DisclosureSEC source: 0001140361-17-001002 · doc1.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:56 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Exercise / conversionCommon Stock | 617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001002 · doc1.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:53 UTC |
Scott Christopher K.CFO & SECRETARY
|
Exercise / conversionRestricted Stock Units · Derivative | 2,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001000 · doc1.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,147 Underlying: Common Stock · 2,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:53 UTC |
Scott Christopher K.CFO & SECRETARY
|
Tax withholdingCommon Stock | 887 | $12.30 | $10,910.10 |
DisclosureSEC source: 0001140361-17-001000 · doc1.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,828 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:53 UTC |
Scott Christopher K.CFO & SECRETARY
|
Exercise / conversionCommon Stock | 2,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001000 · doc1.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 04, 2017 Filed Apr 5, 2017 23:30 UTC Amendment |
ALLEN MONTY KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,562 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-015044 · doc1.xml · derivative · entry 4 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,563 Underlying: Common Stock · 6,562 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 26,250 shares, was granted on 1/1/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. F4 · derivative.expiration_date: This option, representing a right to purchase a total of 26,250 shares, was granted on 1/1/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| January 04, 2017 Filed Apr 5, 2017 23:30 UTC Amendment |
ALLEN MONTY KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-015044 · doc1.xml · derivative · entry 3 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,899 Underlying: Common Stock · 1,898 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Apr 5, 2017 23:30 UTC Amendment |
ALLEN MONTY KDirector
|
GrantCommon Stock | 6,562 | $1.48 | $9,711.76 |
DisclosureSEC source: 0001140361-17-015044 · doc1.xml · nonDerivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,960 Read SEC document |
| January 04, 2017 Filed Apr 5, 2017 23:30 UTC Amendment |
ALLEN MONTY KDirector
|
Exercise / conversionCommon Stock | 1,898 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-015044 · doc1.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This amendment is being filed to remove reference to improperly withheld shares of common stock issued to the reporting person pursuant to the vesting of restricted stock units. Due to an administrative error, upon the vesting of restricted stock units on 1/4/2017, 620 shares of common stock were withheld to satisfy tax withholding obligations as if the reporting person were an employee of the issuer. This error was corrected and the improperly-withheld 620 shares of common stock were issued to the reporting person on 4/3/2017. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 19:53 UTC |
Casey Francis X.VP of Reg & Qual Assurance
|
GrantRestricted Stock Units · Derivative | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090125 · doc1.xml · derivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 19:40 UTC |
Waldman Louis S.Controller
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090121 · doc1.xml · derivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 19:48 UTC |
Nardi Steven M.VP of Manufacturing
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090123 · doc1.xml · derivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 19:32 UTC |
Kennedy JonathanDirector
|
GrantRestricted Stock Units · Derivative | 8,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090120 · doc1.xml · derivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,695 Underlying: Common Stock · 8,695 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2016 Filed Dec 17, 2016 00:59 UTC |
ALLEN MONTY KDirector
|
GrantRestricted Stock Units · Derivative | 8,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090128 · doc1.xml · derivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,695 Underlying: Common Stock · 8,695 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2016 Filed Dec 17, 2016 00:50 UTC |
JOHNSON BRENTExec. VP, Sales & Marketing
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090124 · doc1.xml · derivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2016 Filed Dec 17, 2016 00:56 UTC |
Scott Christopher K.CFO & Secretary
|
GrantRestricted Stock Units · Derivative | 13,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090127 · doc1.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,667 Underlying: Common Stock · 13,667 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2016 Filed Dec 17, 2016 00:44 UTC |
VUOTO ANTHONYDirector
|
GrantRestricted Stock Units · Derivative | 8,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090122 · doc1.xml · derivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,695 Underlying: Common Stock · 8,695 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 12:24 UTC |
Susi Roger E.Director · CEO, President, Chairman · 10% owner
|
PurchaseCommon Stock | 5,000 | $11.24 | $56,190.00 |
DisclosureSEC source: 0001140361-16-088306 · doc1.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $11.15 to $11.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 21:46 UTC |
Susi Roger E.Director · CEO, President, Chairman · 10% owner
|
PurchaseCommon Stock | 5,000 | $10.46 | $52,280.00 |
DisclosureSEC source: 0001140361-16-086963 · doc1.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $10.20 to $10.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.